📋 Clinical Overview

A fixed-dose combination (FDC) of two first-line bactericidal antitubercular drugs. Rifampicin is a rifamycin antibiotic that inhibits bacterial DNA-dependent RNA polymerase. Isoniazid is a prodrug activated by bacterial catalase-peroxidase (KatG), inhibiting mycolic acid synthesis in the mycobacterial cell wall. This combination is a cornerstone of the Directly Observed Treatment, Short-course (DOTS) strategy for tuberculosis in India, significantly improving treatment adherence and reducing the risk of monotherapy and drug resistance.

💊 Dosage & Administration

Adult: One tablet (Rifampicin 600mg + Isoniazid 300mg) once daily, taken on an empty stomach (at least 1 hour before or 2 hours after food), preferably in the morning.

Note: Swallow whole with a full glass of water. MUST be taken on an empty stomach for optimal absorption of rifampicin. If gastrointestinal upset occurs, consult a physician; taking with food significantly reduces rifampicin bioavailability. Pyridoxine (Vitamin B6) 10-50 mg daily is strongly recommended to prevent isoniazid-induced peripheral neuropathy, especially in high-risk groups (diabetics, alcoholics, elderly, malnourished, HIV+).

⚠️ Contraindications

History of severe hypersensitivity (e.g., anaphylaxis, Stevens-Johnson syndrome) to rifampicin, isoniazid, or any component
Concurrent use of strong CYP3A4 substrates with narrow therapeutic index where rapid metabolism can cause life-threatening events (e.g., protease inhibitors for HIV, many direct oral anticoagulants) - requires expert management
Active liver disease or history of severe drug-induced hepatitis from either component
Acute porphyria (rifampicin is porphyrinogenic)

🔬 Mechanism of Action

Rifampicin binds to the beta subunit of bacterial DNA-dependent RNA polymerase, leading to inhibition of RNA synthesis and subsequent bactericidal effect, particularly against actively dividing organisms. Isoniazid, a prodrug, is activated by the mycobacterial catalase-peroxidase enzyme (KatG). The activated form forms a covalent complex with NADH/NAD+, which then inhibits the enoyl-acyl carrier protein reductase (InhA), a key enzyme in the synthesis of mycolic acids—essential components of the mycobacterial cell wall. The combination is synergistic and targets different pathways, reducing the likelihood of resistance.

🤕 Side Effects

Orange/red discoloration of urine, sweat, saliva, tears (harmless but should be explained)
Nausea, vomiting, epigastric discomfort
Skin rash, pruritus
Flu-like syndrome (fever, chills, headache) with intermittent dosing
Transient asymptomatic elevation of liver enzymes

🤰 Special Populations

Pregnancy: Pregnancy Category C (US FDA). Both drugs cross the placenta. Use only if clearly needed and benefit outweighs risk. Well-established use in pregnant women with active TB. Pyridoxine supplementation is essential. Neonatal bleeding due to vitamin K deficiency has been reported; prophylactic vitamin K may be considered.

Driving: Generally safe. However, patients should be cautioned about potential side effects like dizziness, visual disturbances, or confusion that could impair driving ability.

🔄 Drug Interactions

Ketoconazole, Itraconazole, Voriconazole	Rifampicin induces metabolism, drastically reducing azole levels leading to treatment failure.	Major
Oral Contraceptives (Estrogen-based)	Rifampicin induces metabolism, causing contraceptive failure. Alternative non-hormonal methods required.	Major
Warfarin, Acenocoumarol	Rifampicin induces metabolism, reducing anticoagulant effect. Requires frequent INR monitoring and dose adjustment.	Major
Antiretroviral Protease Inhibitors (e.g., Atazanavir, Lopinavir) & NNRTIs (e.g., Nevirapine, Efavirenz)	Complex bidirectional interactions. Rifampicin significantly reduces PI levels. Co-administration requires expert HIV/TB co-management and dose adjustments/alternative regimens.	Major
Prednisone, Dexamethasone	Rifampicin induces metabolism, reducing corticosteroid efficacy. Dose increase may be needed.	Moderate
Oral Hypoglycemics (e.g., Gilbenclamide, Glimepiride)	Rifampicin may reduce efficacy. Monitor blood glucose closely.	Moderate
Phenytoin, Valproate	Rifampicin induces metabolism, reducing anticonvulsant levels. Monitor levels and adjust dose.	Major
Digoxin	Rifampicin reduces serum levels. Monitor digoxin levels.	Moderate
Theophylline	Rifampicin increases clearance, reducing efficacy.	Moderate
Cyclosporine, Tacrolimus	Rifampicin drastically reduces levels, risking transplant rejection.	Major
Acetaminophen (Paracetamol)	Increased risk of hepatotoxicity, especially in overdose. Use with caution.	Moderate
Alcohol	Increased risk of hepatotoxicity with Isoniazid. Synergistic liver damage.	Major
Pyridoxine (Vitamin B6)	Prevents Isoniazid-induced neuropathy. Recommended for co-administration.	Beneficial

🔁 Alternatives to Rimactazid 600

Same composition (Rifampicin (600mg) + Isoniazid (300mg)), different brands:

AKT-3 R-Cinah 600 Macrozide 600 Rifampicin + Isoniazid (Generic)